The Value of CA19-9 After Irreversible Electroporation for Pancreatic Cancer
نویسندگان
چکیده
منابع مشابه
Case report: Irreversible electroporation for locally advanced pancreatic cancer
INTRODUCTION For patients with pancreatic adenocarcinoma who are not candidates for surgical resection, long-term survival is poor, even with currently available systemic and radiation therapy options. However, for those with locally advanced disease who do not have distant metastasis, locoregional control of the tumor has the potential to improve long-term outcomes. A newly developed technolog...
متن کاملUse of irreversible electroporation in unresectable pancreatic cancer.
Irreversible electroporation is a non-thermal injury ablative modality that has been in clinical use since 2008 in the treatment of locally advanced soft tissue tumors. It has been reported to be utilized intraoperatively, laparoscopically or percutaneously. The method of action of IRE relies on a high voltage (maximum 3,000 volts) small microsecond pulse lengths (70 to 90 microseconds) to indu...
متن کاملIrreversible electroporation for the treatment of pancreatic neuroendocrine tumors
BACKGROUNDS/AIMS Resection or enucleation is currently the treatment of choice for small pancreatic neuroendocrine tumors (NETs). Irreversible electroporation is a novel ablative method that is used for locally advanced pancreatic adenocarcinoma, but little data exists for its use for pancreatic NETs. We report an early experience of IRE for early pancreatic NETs. METHODS Between April 2014 a...
متن کامل[Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy].
BACKGROUND AND OBJECTIVE Gemcitabine is used as an effective drug for patients with advanced pancreatic cancer. Serum CA19-9 has been proven as the most sensitive and specific serum marker for pancreatic cancer. This study was to investigate the value of serum CA19-9 in evaluating treatment efficacy and predicting prognosis of patients with pancreatic cancer treated by gemcitabine-based chemoth...
متن کاملComparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer.
BACKGROUND/AIM The performance of the circulating tumor markers carbohydrate antigen 19-9 (CA19-9), matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinase 1 (TIMP-1) were evaluated separately and in combination for their potential value in detecting pancreatic ductal adenocarcinoma. PATIENTS AND METHODS The patients had symptoms of pancreatic cancer. The discriminative s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anticancer Research
سال: 2019
ISSN: 0250-7005,1791-7530
DOI: 10.21873/anticanres.13827